ClinicalTrials.Veeva

Menu

Evaluation of Semi-rigid and Flexible Catheters for Less Invasive Surfactant Administration in Preterm Infants

S

Salzburger Landeskliniken

Status

Completed

Conditions

Neonatology
Perinatal Distress Syndrome

Treatments

Device: Surfactant Administration

Study type

Interventional

Funder types

Other

Identifiers

NCT05024435
415-E/2532/7-2019

Details and patient eligibility

About

The overall aim of this study is to determine the differences between two surfactant administration catheters in preterm infants.

Full description

In this single-center, open-label, randomized-controlled trial, preterm infants requiring surfactant administration after birth, using a standardized minimal invasive protocol, were randomised to two different modes of endotracheal catheterization: Flexible Ch-4 feeding tube inserted using Magill forceps (group 1) and semi-rigid catheter (group 2). Primary outcome was duration of laryngoscopy. Secondary outcomes were complication rate and vital parameters during laryngoscopy.

Enrollment

31 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Preterm infants born less than 37 weeks of gestation
  • Treating physician in charge of admission decides to administer intratracheal surfactant via standardized institution- LISA protocol (regardless of this study) (see Supplement file 1)
  • Written informed consent signed by caregivers or legal representative to participate

Exclusion criteria

  • Refusal to participate in study or not providing written informed consent by caregivers/parents
  • Treating physician decides to use different route of surfactant administration or does not adhere to LISA protocol.
  • Rupture of membranes (ROM) at less than 22 weeks of gestation or more than 6 weeks before birth
  • Estimated birth weight < 3rd percentile using 2013 Fenton growth trajectories
  • Twins with feto-fetal transfusion syndrome (FFTS) and FFTS being the cause of premature delivery
  • Contraindications listed in the LISAcath® or Nasogastric Tube manual (esophageal/pharyngeal varices or other vascular lesions, esophageal/pharyngeal tumor, nasal fracture, skull fracture, known allergy to material)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

31 participants in 2 patient groups

Nasogastric Tube
Experimental group
Treatment:
Device: Surfactant Administration
Lisacath
Experimental group
Treatment:
Device: Surfactant Administration

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems